Overview

Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Clinical study to assess the efficacy, safety, and tolerability of macitentan in subjects with Eisenmenger Syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Actelion
Treatments:
Macitentan